Back
ALPS Internatl Sector Dividends Dogs ETF Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
58
IDOG
ALPS Internatl Sector Dividends Dogs ETF
Last Price:
$38.28
Seasonality Move:
2.76%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.12
Seasonality Move:
10.38%
Buy
58
ALPS Internatl Sector Dividends Dogs ETF (IDOG)
is a Buy
Is ALPS Internatl Sector Dividends Dogs ETF a Buy, Sell or Hold?
-
The current ALPS Internatl Sector Dividends Dogs ETF [IDOG] share price is $38.28. The Score for IDOG is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
IDOG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.00. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IDOG Stock Price Chart
What is ALPS Internatl Sector Dividends Dogs ETF's stock price today?
-
The ALPS Internatl Sector Dividends Dogs ETF share price today is $38.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IDOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
IDOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 55.88 | Buy |
| Chaikin Money Flow: | 29152 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.2 - 38.52) | Buy |
| Bollinger Bands (100): | (35.4 - 37.62) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.26 | Buy |
| Relative Strength Index (14 RSI): | 55.88 | Buy |
| Chaikin Money Flow: | 752304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.76 - 22.42) | Buy |
| Bollinger Bands (100): | (17.71 - 22.25) | Buy |
IDOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.53 | Sell |
| 20-day SMA: | 38.1 | Buy |
| 50-day SMA: | 37.35 | Buy |
| 200-day SMA: | 34.75 | Buy |
| 8-day EMA: | 38.35 | Sell |
| 20-day EMA: | 38.1 | Buy |
| 50-day EMA: | 36.87 | Buy |
| 200-day EMA: | 23.51 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.39 | Buy |
| 20-day SMA: | 21.39 | Buy |
| 50-day SMA: | 20.77 | Buy |
| 200-day SMA: | 31.26 | Sell |
| 8-day EMA: | 15.23 | Buy |
| 20-day EMA: | 8.35 | Buy |
| 50-day EMA: | 3.84 | Buy |
| 200-day EMA: | 1.03 | Buy |
ALPS Internatl Sector Dividends Dogs ETF Earnings Growth & IDOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
ALPS Internatl Sector Dividends Dogs ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||